EDP Biotech Corporation – Trademark Portfolio
Entity Type: 03
EDP Biotech Corporation holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include COLOPLEX and COLOPLEX FIGHT CANCER. DETECT EARLY.. The owner is based in Knoxville, TN.
Suite 110
6701 Baum Drive
Knoxville, TN 37919
Showing of trademarks Trademarks
Trademark Classifications
EDP Biotech Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does EDP Biotech Corporation have?
EDP Biotech Corporation has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 5 cancelled.
What trademark classes does EDP Biotech Corporation file in?
EDP Biotech Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are EDP Biotech Corporation's most well-known trademarks?
EDP Biotech Corporation's registered trademark portfolio includes well-known marks such as COLOPLEX and COLOPLEX FIGHT CANCER. DETECT EARLY.. These are among 2 currently registered trademarks in the portfolio.
What is EDP Biotech Corporation's trademark registration success rate?
EDP Biotech Corporation has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.